amivantamab-vmjw,sacituzumab govitecan,lazertinib,cabozantinib,osimertinib,atezolizumab,enfortumab vedotin
astrazeneca,astellas,genmab,gilead sciences,yuhan corp,exelixis,janssen,seagen,roche
['chrysalis-2', 'ev-301', 'lcsm,(-blcsm)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'bcsm', 'tropics-02', 'cosmic-021']
have you caught up with our #asco22 coverage for yet? head on over to the conference hub for reports on tropics-02, cosmic-021, ev-301, chrysalis &amp; chrysalis-2, and more #bcsm #lcsm #guonc 
medwireNews is an independent online medical news service.